The Effect of Diabetes Mellitus on the Morbidity and Mortality Rates in Patients With COVID-19
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 2,000
- 试验地点
- 1
- 主要终点
- Duration of Hospitalisation
研究概览
简要总结
All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study.
The patients will be divided into two groups, as diabetics and non-diabetics. The COVID-19 patients' medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.
详细描述
All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study.
The patients will be divided into two groups, as diabetics and non-diabetics. The diagnosis of diabetes mellitus will be extracted from the medical records and medical history of the patients hospitalised with COVID-19.
The COVID-19 patients medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients hospitalized for COVID-19
排除标准
- •Patients with known malignancy
- •Pregnant patients
结局指标
主要结局
Duration of Hospitalisation
时间窗: 1 year
The time between admission to hospital and discharge
The need for ICU
时间窗: 1 year
The admission of hospitalized patients to the intensive care unit.
Mortality
时间窗: 1 year
Mortality rates of patients
Lung involvement
时间窗: 1 year
The presence of lung involvement on thorax CT
次要结局
未报告次要终点